
### [MONDO:0018795](http://purl.obolibrary.org/obo/MONDO_0018795)
**Label:** syndromic constitutional thrombocytopenia

**Subclasses:** [MONDO:0010518](http://purl.obolibrary.org/obo/MONDO_0010518) (Wiskott-Aldrich syndrome), [MONDO:0016502](http://purl.obolibrary.org/obo/MONDO_0016502) (Hermansky-Pudlak syndrome without pulmonary fibrosis), [MONDO:0016501](http://purl.obolibrary.org/obo/MONDO_0016501) (Hermansky-Pudlak syndrome with pulmonary fibrosis), [MONDO:0019312](http://purl.obolibrary.org/obo/MONDO_0019312) (Hermansky-Pudlak syndrome), [MONDO:0011555](http://purl.obolibrary.org/obo/MONDO_0011555) (radio-ulnar synostosis-amegakaryocytic thrombocytopenia syndrome), [MONDO:0011071](http://purl.obolibrary.org/obo/MONDO_0011071) (hereditary thrombocytopenia with normal platelets-hematological cancer predisposition syndrome), [MONDO:0011603](http://purl.obolibrary.org/obo/MONDO_0011603) (GNE myopathy), [MONDO:0015912](http://purl.obolibrary.org/obo/MONDO_0015912) (MYH-9 related disease), [MONDO:0020118](http://purl.obolibrary.org/obo/MONDO_0020118) (dense granule disease), 

**Corr. equiv. classes:** [OMIM:605432](http://purl.obolibrary.org/obo/OMIM_605432), [OMIM:601399](http://purl.obolibrary.org/obo/OMIM_601399), [OMIM:614171](http://purl.obolibrary.org/obo/OMIM_614171), [OMIM:614072](http://purl.obolibrary.org/obo/OMIM_614072), [OMIM:614073](http://purl.obolibrary.org/obo/OMIM_614073), [OMIM:153640](http://purl.obolibrary.org/obo/OMIM_153640), [OMIM:155100](http://purl.obolibrary.org/obo/OMIM_155100), [Orphanet:231500](http://www.orpha.net/ORDO/Orphanet_231500), [OMIM:600903](http://purl.obolibrary.org/obo/OMIM_600903), [OMIM:614076](http://purl.obolibrary.org/obo/OMIM_614076), [OMIM:614077](http://purl.obolibrary.org/obo/OMIM_614077), [OMIM:614074](http://purl.obolibrary.org/obo/OMIM_614074), [OMIM:600208](http://purl.obolibrary.org/obo/OMIM_600208), [OMIM:614493](http://purl.obolibrary.org/obo/OMIM_614493), [OMIM:614075](http://purl.obolibrary.org/obo/OMIM_614075), [Orphanet:182050](http://www.orpha.net/ORDO/Orphanet_182050), [OMIM:616216](http://purl.obolibrary.org/obo/OMIM_616216), [OMIM:616738](http://purl.obolibrary.org/obo/OMIM_616738), [Orphanet:79430](http://www.orpha.net/ORDO/Orphanet_79430), [Orphanet:98456](http://www.orpha.net/ORDO/Orphanet_98456), [OMIM:301000](http://purl.obolibrary.org/obo/OMIM_301000), [OMIM:605249](http://purl.obolibrary.org/obo/OMIM_605249), [Orphanet:231531](http://www.orpha.net/ORDO/Orphanet_231531), [Orphanet:280663](http://www.orpha.net/ORDO/Orphanet_280663), [Orphanet:71290](http://www.orpha.net/ORDO/Orphanet_71290), [OMIM:605820](http://purl.obolibrary.org/obo/OMIM_605820), [OMIM:153650](http://purl.obolibrary.org/obo/OMIM_153650), [Orphanet:231512](http://www.orpha.net/ORDO/Orphanet_231512), [Orphanet:231537](http://www.orpha.net/ORDO/Orphanet_231537), [OMIM:617158](http://purl.obolibrary.org/obo/OMIM_617158), [Orphanet:906](http://www.orpha.net/ORDO/Orphanet_906), [OMIM:203300](http://purl.obolibrary.org/obo/OMIM_203300), [Orphanet:602](http://www.orpha.net/ORDO/Orphanet_602), [Orphanet:71289](http://www.orpha.net/ORDO/Orphanet_71289), [OMIM:608233](http://purl.obolibrary.org/obo/OMIM_608233), [OMIM:277970](http://purl.obolibrary.org/obo/OMIM_277970), 

**Class expressions from DL-Learner:**

- [HP:0001872](http://purl.obolibrary.org/obo/HP_0001872) (Abnormality of thrombocytes) 51.52%
- [HP:0003010](http://purl.obolibrary.org/obo/HP_0003010) (Prolonged bleeding time) and (not ([HP:0001928](http://purl.obolibrary.org/obo/HP_0001928) (Abnormality of coagulation))) 51.23%
- [HP:0003010](http://purl.obolibrary.org/obo/HP_0003010) (Prolonged bleeding time) and (not ([HP:0003256](http://purl.obolibrary.org/obo/HP_0003256) (Abnormality of the coagulation cascade))) 50.00%
- [HP:0003010](http://purl.obolibrary.org/obo/HP_0003010) (Prolonged bleeding time) and (not ([HP:0012823](http://purl.obolibrary.org/obo/HP_0012823) (Clinical modifier))) 48.88%
- [HP:0003010](http://purl.obolibrary.org/obo/HP_0003010) (Prolonged bleeding time) and (not ([HP:0001654](http://purl.obolibrary.org/obo/HP_0001654) (Abnormality of the heart valves))) 48.88%
- [HP:0000421](http://purl.obolibrary.org/obo/HP_0000421) (Epistaxis) and [HP:0001872](http://purl.obolibrary.org/obo/HP_0001872) (Abnormality of thrombocytes) 48.44%
- [HP:0000421](http://purl.obolibrary.org/obo/HP_0000421) (Epistaxis) and [HP:0002715](http://purl.obolibrary.org/obo/HP_0002715) (Abnormality of the immune system) 47.86%
- [HP:0003010](http://purl.obolibrary.org/obo/HP_0003010) (Prolonged bleeding time) and (not ([HP:0012145](http://purl.obolibrary.org/obo/HP_0012145) (Abnormality of multiple cell lineages in the bone marrow))) 47.86%
- [HP:0003010](http://purl.obolibrary.org/obo/HP_0003010) (Prolonged bleeding time) and (not ([HP:0011974](http://purl.obolibrary.org/obo/HP_0011974) (Myelofibrosis))) 47.86%
- [HP:0003010](http://purl.obolibrary.org/obo/HP_0003010) (Prolonged bleeding time) and (not ([HP:0010989](http://purl.obolibrary.org/obo/HP_0010989) (Abnormality of the intrinsic pathway))) 47.86%
- [HP:0003010](http://purl.obolibrary.org/obo/HP_0003010) (Prolonged bleeding time) and (not ([HP:0005261](http://purl.obolibrary.org/obo/HP_0005261) (Joint hemorrhage))) 47.86%
- [HP:0003010](http://purl.obolibrary.org/obo/HP_0003010) (Prolonged bleeding time) and (not ([HP:0003812](http://purl.obolibrary.org/obo/HP_0003812) (Phenotypic variability))) 47.86%
- [HP:0003010](http://purl.obolibrary.org/obo/HP_0003010) (Prolonged bleeding time) and (not ([HP:0200006](http://purl.obolibrary.org/obo/HP_0200006) (Slanting of the palpebral fissure))) 46.91%
- [HP:0003010](http://purl.obolibrary.org/obo/HP_0003010) (Prolonged bleeding time) and (not ([HP:0100886](http://purl.obolibrary.org/obo/HP_0100886) (Abnormality of globe location))) 46.91%
- [HP:0003010](http://purl.obolibrary.org/obo/HP_0003010) (Prolonged bleeding time) and (not ([HP:0040064](http://purl.obolibrary.org/obo/HP_0040064) (Abnormality of limbs))) 46.91%


